Anti-PD-1 plus anti-angiogenesis combined with chemotherapy in patients with HER2-negative advanced or metastatic gastric cancer: a multi-institutional retrospective study

BACKGROUND: Immunotherapy plus chemotherapy have been confirmed to be effective in treating advanced or metastatic gastric cancer (GC). Anti- programmed death-1 (PD-1) plus antiangiogenic agents have shown promising activity and tolerant toxicity in subsequent therapy of late-stage gastric cancer. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tongpeng, Wang, Wenjie, Bao, Ruikang, Xia, Xihua, Zhang, Junling, Huang, Mengli, Chen, Xiaofeng, Wang, Rong, Zhang, Hao, Liu, Xisheng, Li, Qiong, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007938/
https://www.ncbi.nlm.nih.gov/pubmed/36915465
http://dx.doi.org/10.21037/jgo-23-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007938/
https://www.ncbi.nlm.nih.gov/pubmed/36915465
http://dx.doi.org/10.21037/jgo-23-73

Ejemplares similares